ReviewClinical & experimental metastasis2009
Gene expression profiles and breast cancer metastasis: a genetic perspective.
Review in Clinical & experimental metastasis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.Oncotarget · 2018Article
- Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics.Frontiers in oncology · 2018Article
- Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2013Article
- Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.Breast cancer research and treatment · 2013Article
- The role of the CDH1 promoter hypermethylation in the axillary lymph node metastasis and prognosis.Journal of breast cancer · 2013Article
- Genomics screens for metastasis genes.Cancer metastasis reviews · 2012Review
- A methodological approach to unravel organ-specific breast cancer metastasis.Journal of mammary gland biology and neoplasia · 2012Review
- NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.Molecular biology of the cell · 2012Article
- The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.The Journal of clinical investigation · 2011Article
- Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers.BMC cancer · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The majority of cancer mortality is attributed to metastasis, which is the spread of tumor cells to a secondary site. Several studies have demonstrated that the genetic background on which a tumor arises has a major effect on both metastatic efficiency and on predictive gene expression profiles. These observations suggest that there is variability in metastasis frequency between individuals and that some individuals could be more prone to secondary tumor formation and development than others. Thus, genetic background might have important clinical implications in metastasis detection, management and prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.